LAS VEGAS Case Report Form 1 Intra-Operative
|
|
- Avice White
- 6 years ago
- Views:
Transcription
1 LAS VEGAS Case Report Form 1 Intra-Operative Patient Informed Consent 1. Informed consent applicable: yes no (choose no if waived by local EC) 1.1 If applicable; was consent obtained? yes no 1.2 If yes, Date of informed consent [<Date of surgery]: Demographic data 2. Sex: male female 3. Age [18-110]: years 4. Date of birth [<=14-JAN-1995]: 5. Ethnicity/Race: caucasian black ethnicity pacific islander hispanic native american asian other 6. Height available? yes no 6.1 If yes, specify [ ]: cm 7. Weight available? yes no 7.1 If yes, specify [30-300]: kg 8. ASA score: Functional status: non-dependent partially dependent totally dependent 10. Current smoker: yes no 11. Chronic co-morbidity: yes none 11.1 If yes, tick all that apply liver cirrhosis metastatic cancer chronic kidney failure COPD heart failure obstructive sleep apnea any neuromuscular disease affecting the respiratory system 12. Respiratory infection: < 30 days ago yes no 13. Recent transfusion of PRBC: < 24 hrs ago yes no 13.1 If yes, number of PRBC units [0-20]: units 14. Present MV or recent MV: < 30 days ago yes no 14.1 If yes, indication of MV: Saturation and Laboratory results 15. SpO 2 (pre-operative) available? yes no breathing room air in supine position 15.1 If yes, what is the percentage [0-100]? % Most recent blood results if clinically available (taken no longer than 28 days before surgery): 16. Hb available? yes no 16.1 If yes, specify:. mmol/l [0.5-14] g/dl [0.5-25] choose unit 17. Leukocytes available? yes no 17.1 If yes, specify: x10^9/l [0-60] cells/mm^3 [ ] choose unit 18. Creatinine available? yes no 18.1 If yes, specify:. μmol/l [ ] mg/dl [0.1-11] choose unit LAS VEGAS_CRF1_Intra-Operative, version #2.1 dated 28 September 2012 page 1 of 6
2 Surgical procedure 17. Urgency of surgery: Elective Urgent Emergency 18. Planned duration of surgery (hrs): 2 >2 to 3 > Surgical procedure: tick all that apply Lower gastro-intestinal Kidney Head and Neck Upper gastro-intestinal Urological Plastics / Cutaneous Hepato-biliary / Pancreas Gynaecological surgery Breast Carotid endarterectomy Endocrine surgery Bone & joint surgery Peripheral vascular Transplant Spine Aortic surgery Lung / Pleural surgery Trauma Neurosurgery Other procedure 20. Surgical technique: tick all that apply One-lung ventilation during procedure Open abdominal surgery Open thoracic surgery Laparoscopic surgery Thoracoscopic surgery Laparoscopic assisted Thoracoscopic assisted Peripheral None of the above Intra-operative data 21. Breathing circuit: Open Closed Semi-open Semi-closed 22. Tube type: Endotracheal tube Supra-glottic device (e.g. LMA) choose single most appropriate Endobronchial blocker Double-lumen endotracheal tube via tracheostomy Nasal endotracheal tube 23. Epidural anesthesia: yes no 24. Antibiotic prophylaxis: yes no 25. Neuromuscular monitoring: none TOF 25.1 If TOF, specify monitoring by: EMG MMG AMG choose single most appropriate Duration anesthesia 26. Time & date start induction : [0-23hrs] [0-59min] [>=14FEB-2013] h h m m 27. Time & date extubation or : discharge from OR if MV remains h h m m [0-23hrs] [0-59min] [>=14FEB-2013] Duration surgery 28. Time & date start procedure : [0-23hrs] [0-59min] [>=14FEB-2013] h h m m 29. Time & date stop procedure : [0-23hrs] [0-59min] [>=14FEB-2013] h h m m LAS VEGAS_CRF1_Intra-Operative, version #2.1 dated 28 September 2012 page 2 of 6
3 Intra-Operative Ventilatory settings MV Settings Induction 30. Ventilatory mode tick most appropriate 31. Ppeak [0-60] 32. Pplateau [10-50] if available 33. Pmean [10-50] 34. TV [ mL] 35. PEEP [0-20] 36. RR [1-60/mn] 37. RM 37.1 if yes; tick all that apply yes no Hour 1 VC PC PSV Spon Other yes no VC PC PSV Spon Other Hour 2 yes no Hour 3 VC PC PSV Spon Other yes no VC PC PSV Spon Other Hour 4 yes no Hour 5 VC PC PSV Spon Other yes no Hour 6 VC PC PSV Spon Other yes no Hour 7 VC PC PSV Spon Other yes no VC PC PSV Spon Other LAS VEGAS_CRF1_Intra-Operative, version #2.1 dated 28 September 2012 page 3 of 6
4 Monitored parameter 38. SpO 2 % [0-100] 39. etco 2 [5-100 mmhg] [ kpa] 40. FiO 2 % [20-100] 41. MAPmmHg [20-200] 42. HR bpm [10-300] Induction. tick unit used Hour 1. tick unit used Hour 2. tick unit used Hour 3. tick unit used Hour 4. tick unit used Hour 5. tick unit used Hour 6. tick unit used Hour 7. tick unit used Parameters at end of surgery 43. Temperature available? yes no 43.1 If yes, specify:. o C [ ] o F [ ]choose unit 44. Hb available? yes no 44.1 If yes, specify:. mmol/l [0.5-14] g/dl [0.5-25] choose unit Intra-operative fluids (total during procedure) 45. Crystalloids available? yes no 45.1 If yes, specify [ ]: ml 46. Colloids available? yes no 46.1 If yes, specify [ ]: ml 47. Albumin available? yes no 47.1 If yes, specify [ ]: ml 48. Packed red blood cells available? yes no 48.1 If yes, specify [0-20]: units Intra-operative medication 49. Opioids: yes no 49.1 If yes, specify type: short-acting long-acting choose single most appropriate 50. Hypnotic agents: total intravenous volatile halogenated agents tick all that apply 51. Muscle paralysis agents: yes no 52. Neuromuscular blockade reversal agents: yes no LAS VEGAS_CRF1_Intra-Operative, version #2.1 dated 28 September 2012 page 4 of 6
5 Intra-operative complications Occurrence of complications related to the ventilation strategy during procedure 53. Any de saturation: yes no defined as SpO 2 < 92% 54. Need for unplanned recruitment maneuver: yes no ventilatory strategies aimed to restore lung aeration 55. Need for ventilatory pressure reduction: yes no ventilatory strategies aimed to lower Ppeak/Pplateau 56. New onset of expiratory flow limitation: yes no defined as expiratory flow higher than zero at end-expiration as suggested by visual analysis of the flow curve 57. Hypotension: yes no defined as SAP < 90mmHg for 3 min or longer 58. Need for vaso-active drugs: yes no any vaso-active drug given to correct hypotension 59. Any new arrhythmias: yes no defined as new onset of AF, VT, SVT or VF LAS VEGAS_CRF1_Intra-Operative, version #2.1 dated 28 September 2012 page 5 of 6
6 Guide intra-operative values Urgency surgery: Emergency: non-elective surgery performed when the patient's life or well-being is in direct jeopardy Urgent: surgery required within < 48 hrs Elective: surgery that is scheduled in advance because it does not involve a medical emergency Ventilatory Mode: - Volume Control: VC - Pressure Control: PC - Pressure Support: PSV - Spontaneous: Spon - Other (for example HFOV, jet ventilation, SIMV) Recruitment Maneuvers (RM): - Incremental PEEP (PEEP): stepwise increases in PEEP at constant tidal volume, mostly in steps of 5 cmh 20, until peak/plateau positive airway pressure above 30 cmh 20 is reached. PEEP is sustained for 3 or more breaths and then returned back to baseline ventilation. - Tidal volume recruitment (TV): stepwise increases in tidal volume until peak/plateau positive airway pressure above 30 cmh 20 is reached at constant PEEP level. At least 3 breaths with the plateau pressure of above 30 cmh 20 are performed, before returning back to baseline ventilation. - Combined tidal and PEEP recruitment (TV/PEEP): PEEP and tidal volume are both stepwise increased to reach a plateau pressure above 30 cmh 20. At least 3 breaths with the plateau pressure > 30 cmh 20 are performed, before returning back to baseline ventilation. - Inspiratory holds (Insp): also called CPAP maneuvers. During this kind of maneuver a positive airway pressure above 30 cmh 20 is applied for 10 to 30 seconds and then returned back to baseline ventilation. - Sustained inflation with bag (Bag): manual hyperinflation using balloon/bag. New onset arrhythmias: Defined as new onset of atrial fibrillation [AF], sustained ventricular tachycardia [VT], supraventricular tachycardia [SVT], and ventricular fibrillation [VF]. For further definitions of AF, VT, SVT and VF; see Appendix 1 of protocol Neuromuscular function evaluation for residual curarization: Train-of-four stimulation (TOF) TOF ratio measured by: - electromyography (EMG) - mechanomyography (MMG) - acceleromyography (AMG) Opioids: Short-acting: remifentanil, alfentanil Long-acting: fentanil, sufentanil, morphine LAS VEGAS_CRF1_Intra-Operative, version #2.1 dated 28 September 2012 page 6 of 6
7 LAS VEGAS Case Report Form 2A - Non Critical Care Follow up DAY 0 Post-Operative Time: from end of surgery to 23:59h 1. Day 0 follow up performed? yes no 2. If yes, date [=Date of surgery]: Post-operative residual curarization 3. Post-operative residual curarization: yes no defined as TOF ratio < If yes, specify type of TOF monitoring: EMG MMG AMG choose single most appropriate 4. Neuromuscular blockade antagonized? yes no Pulmonary complications 5. Need for O 2 therapy? need for O 2 standard care no due to PaO 2 <60 mmhg or SpO 2 <90% in room air or standard care in PACU 5.1 If O 2 is supplemented, specify FiO 2 [20-100] % conversion O 2 to FiO 2; see Appendix 2 in protocol 6. Respiratory failure? yes no PaO 2 < 60 mmhg or SpO 2 < 90% despite O 2 therapy or need for non-invasive MV (NIV) 6.1 If NIV is applied, specify type of interface mask helmet 7. Pneumonia? new no presence of new or progressive radiographic infiltrate plus at least two of three clinical features (fever >38 C or >100.4 F, leukocytosis or leucopenia and purulent secretions) 8. ARDS? new no according to Berlin definition of ARDS 9. Pneumothorax? new no air in the pleural space with no vascular bed surrounding the visceral pleura on CXR Clinical course 10. MV after exit operating room? yes no 10.1 If yes, MV continuated after exit operating room, specify: planned unplanned 10.2 If unplanned: continued re-intubation 11. Critical Care admission directly after surgery? yes no 11.1 If yes, specify planned or unplanned: planned unplanned Lost to follow-up 12. Lost to follow-up? yes no 12.1 If yes, specify: discharge to home informed consent retracted deceased transfer to other hospital other 12.2 If other, specify reason: In case of Critical Care admission or prolonged MV please: complete this page and then proceed to CRF 2B, page 1 LAS VEGAS_CRF2A_Non Critical Care F/U, Final version #2.1 dated 28 September 2012 page 1 of 6
8 1. Day 1 follow up performed? yes no 2. If yes, date [=Date of surgery+1]: Pulmonary complications 3. Need for O 2 therapy? new O 2 continued standard care no due to PaO 2 < 60 mmhg or SpO 2 < 90% in room air or standard care 3.1 If O 2 is supplemented, specify FiO 2 [20-100] % conversion O 2 to FiO 2; see Appendix 2 in protocol 4. Respiratory failure? new continued no PaO 2 < 60 mmhg or SpO 2 < 90% despite O 2 therapy or need for non-invasive MV (NIV) 4.1 If NIV is applied, specify type of interface mask helmet 5. Pneumonia? new continued no presence of new or progressive radiographic infiltrate plus at least two of three clinical features (fever >38 C or >100.4 F, leukocytosis or leucopenia and purulent secretions) 6. ARDS? new continued no according to Berlin definition of ARDS 7. Pneumothorax? new continued no air in the pleural space with no vascular bed surrounding the visceral pleura on CXR Clinical course LAS VEGAS Non Critical Care Follow up DAY 1 Post-Operative Time: from 00:00h to 23:59h 8. Any new mechanical ventilation? yes no 9. Any new admission to Critical Care? yes no Lost to follow-up 10. Lost to follow-up? yes no 10.1 If yes, specify: discharge to home informed consent retracted deceased transfer to other hospital other 10.2 If other, specify reason: In case of Critical Care admission or prolonged MV please: complete this page and then proceed to CRF 2B, page 1 LAS VEGAS_CRF2A_Non Critical Care F/U, Final version #2.1 dated 28 September 2012 page 2 of 6
9 1. Day 2 follow up performed? yes no 2. If yes, date [=Date of surgery+1]: Pulmonary complications 3. Need for O 2 therapy? new O 2 continued standard care no due to PaO 2 < 60 mmhg or SpO 2 < 90% in room air or standard care 3.1 If O 2 is supplemented, specify FiO 2 [20-100] % conversion O 2 to FiO 2; see Appendix 2 in protocol 4. Respiratory failure? new continued no PaO 2 < 60 mmhg or SpO 2 < 90% despite O 2 therapy or need for non-invasive MV (NIV) 4.1 If NIV is applied, specify type of interface mask helmet 5. Pneumonia? new continued no presence of new or progressive radiographic infiltrate plus at least two of three clinical features (fever >38 C or >100.4 F, leukocytosis or leucopenia and purulent secretions) 6. ARDS? new continued no according to Berlin definition of ARDS 7. Pneumothorax? new continued no air in the pleural space with no vascular bed surrounding the visceral pleura on CXR Clinical course LAS VEGAS Non Critical Care Follow up DAY 2 Post-Operative Time: from 00:00h to 23:59h 8. Any new mechanical ventilation? yes no 9. Any new admission to Critical Care? yes no Lost to follow-up 10. Lost to follow-up? yes no 10.1 If yes, specify: discharge to home informed consent retracted deceased transfer to other hospital other 10.2 If other, specify reason: In case of Critical Care admission or prolonged MV please: complete this page and then proceed to CRF 2B, page 1 LAS VEGAS_CRF2A_Non Critical Care F/U, Final version #2.1 dated 28 September 2012 page 3 of 6
10 LAS VEGAS Non Critical Care Follow up DAY 3 Post-Operative Time: from 00:00h to 23:59h 1. Day 3 follow up performed? yes no 2. If yes, date [=Date of surgery+1]: Pulmonary complications 3. Need for O 2 therapy? new O 2 continued standard care no due to PaO 2 < 60 mmhg or SpO 2 < 90% in room air or standard care 3.1 If O 2 is supplemented, specify FiO 2 [20-100] % conversion O 2 to FiO 2; see Appendix 2 in protocol 4. Respiratory failure? new continued no PaO 2 < 60 mmhg or SpO 2 < 90% despite O 2 therapy or need for non-invasive MV (NIV) 4.1 If NIV is applied, specify type of interface mask helmet 5. Pneumonia? new continued no presence of new or progressive radiographic infiltrate plus at least two of three clinical features (fever >38 C or >100.4 F, leukocytosis or leucopenia and purulent secretions) 6. ARDS? new continued no according to Berlin definition of ARDS 7. Pneumothorax? new continued no air in the pleural space with no vascular bed surrounding the visceral pleura on CXR Clinical course 8. Any new mechanical ventilation? yes no 9. Any new admission to Critical Care? yes no Lost to follow-up 10. Lost to follow-up? yes no 10.1 If yes, specify: discharge to home informed consent retracted deceased transfer to other hospital other 10.2 If other, specify reason: In case of Critical Care admission or prolonged MV please: complete this page and then proceed to CRF 2B, page 1 LAS VEGAS_CRF2A_Non Critical Care F/U, Final version #2.1 dated 28 September 2012 page 4 of 6
11 1. Day 4 follow up performed? yes no 2. If yes, date [=Date of surgery+1]: Pulmonary complications 3. Need for O2 therapy? new O 2 continued standard care no due to PaO 2 < 60 mmhg or SpO 2 < 90% in room air or standard care 3.1 If O 2 is supplemented, specify FiO 2 [20-100] % conversion O 2 to FiO 2; see Appendix 2 in protocol 4. Respiratory failure? new continued no PaO 2 < 60 mmhg or SpO 2 < 90% despite O 2 therapy or need for non-invasive MV (NIV) 4.1 If NIV is applied, specify type of interface mask helmet 5. Pneumonia? new continued no presence of new or progressive radiographic infiltrate plus at least two of three clinical features (fever >38 C or >100.4 F, leukocytosis or leucopenia and purulent secretions) 6. ARDS? new continued no according to Berlin definition of ARDS 7. Pneumothorax? new continued no air in the pleural space with no vascular bed surrounding the visceral pleura on CXR Clinical course 8. Any new mechanical ventilation? yes no 9. Any new admission to Critical Care? yes no Lost to follow-up LAS VEGAS Non Critical Care Follow up DAY 4 Post-Operative Time: from 00:00h to 23:59h 10. Lost to follow-up? yes no 10.1 If yes, specify: discharge to home informed consent retracted deceased transfer to other hospital other 10.2 If other, specify reason: In case of Critical Care admission or prolonged MV please: complete this page and then proceed to CRF 2B, page 1 LAS VEGAS_CRF2A_Non Critical Care F/U, Final version #2.1 dated 28 September 2012 page 5 of 6
12 1. Day 5 follow up performed? yes no 2. If yes, date [=Date of surgery+1]: Pulmonary complications 3. Need for O2 therapy? new O 2 continued standard care no due to PaO 2 < 60 mmhg or SpO 2 < 90% in room air or standard care 3.1 If O 2 is supplemented, specify FiO 2 [20-100] % conversion O 2 to FiO 2; see Appendix 2 in protocol 4. Respiratory failure? new continued no PaO 2 < 60 mmhg or SpO 2 < 90% despite O 2 therapy or need for non-invasive MV (NIV) 4.1 If NIV is applied, specify type of interface mask helmet 5. Pneumonia? new continued no presence of new or progressive radiographic infiltrate plus at least two of three clinical features (fever >38 C or >100.4 F, leukocytosis or leucopenia and purulent secretions) 6. ARDS? new continued no according to Berlin definition of ARDS 7. Pneumothorax? new continued no air in the pleural space with no vascular bed surrounding the visceral pleura on CXR Clinical course LAS VEGAS Non Critical Care Follow up DAY 5 Post-Operative Time: from 00:00h to 23:59h 8. Any new mechanical ventilation? yes no 9. Any new admission to Critical Care? yes no Lost to follow-up 10. Lost to follow-up? yes no 10.1 If yes, specify: discharge to home informed consent retracted deceased transfer to other hospital other 10.2 If other, specify reason: In case of Critical Care admission or prolonged MV please: complete this page and then proceed to CRF 2B, page 1 LAS VEGAS_CRF2A_Non Critical Care F/U, Final version #2.1 dated 28 September 2012 page 6 of 6
13 LAS VEGAS Case Report Form 2B - Critical Care Follow up (F/U) Admission Every investigator should fill this page for every patient admitted to Critical Care Admission to Critical Care 1. ICU Admission day: day 0 day 1 day 2 day 3 day 4 day 5 Reason(s) for Critical Care admission: tick all that apply 2. Respiratory failure yes no 3. Need for intensive monitoring yes no 4. Circulatory failure yes no 5. Routine care (i.e. planned) yes no 6. Airway protection yes no 7. Respiratory arrest in 24 hours prior to Critical Care admission yes no 8. Cardiac arrest in 24 hours prior to Critical Care admission yes no Mechanical Ventilation (invasive or non-invasive) 9. Invasive mechanical ventilation? yes no 10. Non-invasive mechanical ventilation? yes no If yes, specify type of interface mask helmet Reason(s) for Mechanical Ventilation: 11. Respiratory failure yes no 12. Pneumonia yes no 13. Aspiration yes no 14. Cardiac overload yes no 15. Airway protection yes no 16. Fatigue yes no 17. Coma (GCS<6) yes no 18. Post-Operative MV yes no If you have chosen to perform Critical Care follow-up, please continue data-entry on the F/U page corresponding with ICU admission day E.g. if patient is transferred to ICU on day 3; fill in Critical Care F/U for day 3 (page 8) and mark day 0, 1 and 2 not performed LAS VEGAS_CRF2B_Critical Care F/U, Final version #2.1 dated 28 September 2012 page 1 of 14
14 LAS VEGAS Critical Care Follow up DAY 0 Post-Operative Time: from end of surgery to 23:59h 1. Day 0 follow up performed? yes no 2. If yes, date [>=14-FEB-2013]: 3. APACHE II score [0-71]: in case of new admission (score within first 24h) Daily score (at first hour of Critical Care admission) 4. SOFA score [0-24]: 5. Invasive mechanical ventilation? yes no 5.1 Total hours of invasive MV [0-24]: hours from end of surgery to 23:59h 6. Non-invasive mechanical ventilation? yes no 6.1 If non-invasive, specify type of interface mask helmet 6.2 Total hours of non-invasive MV [0-24]: hours from end of surgery to 23:59h 7. Tracheal extubation on day 0? n/a yes no 8. Re-intubation on day 0? n/a yes no Mechanical Ventilation from end of surgery to 23:59h 9. Hours of controlled MV [0-24]: hours i.e. pressure control; volume control 10. Hours of assisted MV [0-24]: hours i.e. ASB 11. Hours of combined controlled/assisted MV [0-24]: hours i.e. ASV, SIMV 12. Hours of CPAP [0-24]: hours Ppeak [20-60 cmh2o] Pplat (if available) [10-50 cmh2o] TV [ ml] PEEP [0-30 cmh2o] Resp Rate [1-60 /min] Highest Lowest Highest Lowest Highest Lowest Highest Lowest Highest Lowest RM FiO2 [20-100%] ph [ ] PaCO2 [ mmhg] or [1-40 kpa] PaO2 [ mmhg] or [1-80 kpa] Yes* No Highest Lowest Highest Lowest Highest Lowest Highest Lowest 23.1 *if yes, tick all that apply LAS VEGAS_CRF2B_Critical Care F/U, Final version #2.1 dated 28 September 2012 page 2 of 14
15 Extra-pulmonary organ failure 32. Pneumonia? yes no presence of a new or progressive radiographic infiltrate plus at least two of three clinical features (fever >38 C or >100.4 F, leucocytosis or leucopenia and purulent secretions) 33. ARDS? yes no 33.1 If yes, specify severity of ARDS mild moderate severe according to Berlin definition of ARDS 34. Pneumothorax? yes no air in the pleural space with no vascular bed surrounding the visceral pleura on CXR Extra-pulmonary organ failure 35. Acute kidney failure? yes no 35.1 If yes, staging by RIFLE criteria risk injury failure loss end-stage definitions on page Renal replacement therapy? yes no 37. Circulatory failure? yes no defined as; need for vaso-active drugs 38. Any new arrhythmias? yes no definition on page 14 Transfusion of fluids 39. Transfusion PRBC? yes no 39.1 Number of PRBC units given [0-20]: 40. Transfusion Fresh Frozen Plasma? yes no 40.1 Number of FFP units given [0-20]: 41. Transfusion platelets? yes no 41.1 Number of platelets units given [1-5]: 42. Fluid balance available? yes no 42.1 If yes, specify volume [ ]: ml 42.2 If yes, balance positive or negative positive negative End of Critical Care stay / Lost to follow-up 43. End of CriticaI Care stay? yes no 43.1 If yes, specify: discharge to ward transfer to other hospital deceased discharge to home 44. At end of CriticaI Care stay, specify total duration of stay [0-144]: hours 45. Lost to follow-up? yes no 45.1 If yes, specify: informed consent retracted other 45.2 If other, specify reason: If discharge to ward; please continue data recording on CRF 2A Non Critical Care LAS VEGAS_CRF2B_Critical Care F/U, Final version #2.1 dated 28 September 2012 page 3 of 14
16 LAS VEGAS Critical Care Follow up DAY 1 Post-Operative Time: from 00:00 h to 23:59h 1. Day 1 follow up performed? yes no 2. If yes, date [>14-FEB-2013]: 3. APACHE II score [0-71]: If APACHE II is already scored on a previous day, in case of new admission (score within first 24h) please fill 00 Daily score (on morning round; i.e. closest to 08:00 AM. In case of new admission at first hour of CCU admission) 4. SOFA score [0-24]: 5. Invasive mechanical ventilation? yes no 5.1 Total hours of invasive MV [0-24]: hours from 00:00h to 23:59h 6. Non-invasive mechanical ventilation? yes no 6.1 If non-invasive, specify type of interface mask helmet 6.2 Total hours of non-invasive MV [0-24]: hours from 00:00h to 23:59h 7. Tracheal extubation on day 1? n/a yes no 8. Re-intubation on day 1? n/a yes no Mechanical Ventilation from 00:00 h to 23:59h 46. Hours of controlled MV [0-24]: hours i.e. pressure control; volume control 47. Hours of assisted MV [0-24]: hours i.e. ASB 48. Hours of combined controlled/assisted MV [0-24]: hours i.e. ASV, SIMV 49. Hours of CPAP [0-24]: hours Ppeak [20-60 cmh2o] Pplat (if available) [10-50 cmh2o] TV [ ml] PEEP [0-30 cmh2o] Resp Rate [1-60 /min] Highest Lowest Highest Lowest Highest Lowest Highest Lowest Highest Lowest RM FiO2 [20-100%] ph [ ] PaCO2 [ mmhg] or [1-40 kpa] PaO2 [ mmhg] or [1-80 kpa] Yes* No Highest Lowest Highest Lowest Highest Lowest Highest Lowest 60.1 *if yes, tick all that apply LAS VEGAS_CRF2B_Critical Care F/U, Final version #2.1 dated 28 September 2012 page 4 of 14
17 Pulmonary complications 9. Pneumonia? yes no presence of a new or progressive radiographic infiltrate plus at least two of three clinical features (fever >38 C or >100.4 F, leucocytosis or leucopenia and purulent secretions) 10. ARDS? yes no 10.1 If yes, specify severity of ARDS mild moderate severe according to Berlin definition of ARDS 11. Pneumothorax? yes no air in the pleural space with no vascular bed surrounding the visceral pleura on CXR Extra-pulmonary organ failure 12. Acute kidney failure? yes no 12.1 If yes, staging by RIFLE criteria risk injury failure loss end-stage definitions on page Renal replacement therapy? yes no 14. Circulatory failure? yes no defined as; need for vaso-active drugs 15. Any new arrhythmias? yes no definition on page 14 Transfusion of fluids 16. Transfusion PRBC? yes no 16.1 Number of PRBC units given [0-20]: 17. Transfusion Fresh Frozen Plasma? yes no 17.1 Number of FFP units given [0-20]: 18. Transfusion platelets? yes no 18.1 Number of platelets units given [1-5]: 19. Fluid balance available? yes no 19.1 If yes, specify volume [ ]: ml 19.2 If yes, balance positive or negative positive negative End of Critical Care stay / Lost to follow-up 20. End of CriticaI Care stay? yes no 20.1 If yes, specify: discharge to ward transfer to other hospital deceased discharge to home 21. At end of CriticaI Care stay, specify total duration of stay [0-144]: hours 22. Lost to follow-up? yes no 22.1 If yes, specify: informed consent retracted other 22.2 If other, specify reason: If discharge to ward; please continue data recording on CRF 2A Non Critical Care Follow up LAS VEGAS_CRF2B_Critical Care F/U, Final version #2.1 dated 28 September 2012 page 5 of 14
18 LAS VEGAS Critical Care Follow up DAY 2 Post-Operative Time: from 00:00 h to 23:59h 1. Day 2 follow up performed? yes no 2. If yes, date [>14-FEB-2013]: 3. APACHE II score [0-71]: If APACHE II is already scored on a previous day, in case of new admission (score within first 24h) please fill 00 Daily score (on morning round; i.e. closest to 08:00 AM. In case of new admission at first hour of CCU admission) 23. SOFA score [0-24]: 24. Invasive mechanical ventilation? yes no 24.1 Total hours of invasive MV [0-24]: hours from 00:00h to 23:59h 25. Non-invasive mechanical ventilation? yes no 25.1 If non-invasive, specify type of interface mask helmet 25.2 Total hours of non-invasive MV [0-24]: hours from 00:00h to 23:59h 26. Tracheal extubation on day 2? n/a yes no 27. Re-intubation on day 2? n/a yes no Mechanical Ventilation from 00:00 h to 23:59h 69. Hours of controlled MV [0-24]: hours i.e. pressure control; volume control 70. Hours of assisted MV [0-24]: hours i.e. ASB 71. Hours of combined controlled/assisted MV [0-24]: hours i.e. ASV, SIMV 72. Hours of CPAP [0-24]: hours Ppeak [20-60 cmh2o] Pplat (if available) [10-50 cmh2o] TV [ ml] PEEP [0-30 cmh2o] Resp Rate [1-60 /min] Highest Lowest Highest Lowest Highest Lowest Highest Lowest Highest Lowest RM FiO2 [20-100%] ph [ ] PaCO2 [ mmhg] or [1-40 kpa] PaO2 [ mmhg] or [1-80 kpa] Yes* No Highest Lowest Highest Lowest Highest Lowest Highest Lowest 83.1 *if yes, tick all that apply LAS VEGAS_CRF2B_Critical Care F/U, Final version #2.1 dated 28 September 2012 page 6 of 14
19 Pulmonary complications 28. Pneumonia? yes no presence of a new or progressive radiographic infiltrate plus at least two of three clinical features (fever >38 C or >100.4 F, leucocytosis or leucopenia and purulent secretions) 29. ARDS? yes no 29.1 If yes, specify severity of ARDS mild moderate severe according to Berlin definition of ARDS 30. Pneumothorax? yes no air in the pleural space with no vascular bed surrounding the visceral pleura on CXR Extra-pulmonary organ failure 31. Acute kidney failure? yes no 31.1 If yes, staging by RIFLE criteria risk injury failure loss end-stage definitions on page Renal replacement therapy? yes no 33. Circulatory failure? yes no defined as; need for vaso-active drugs 34. Any new arrhythmias? yes no definition on page 14 Transfusion of fluids 35. Transfusion PRBC? yes no 35.1 Number of PRBC units given [0-20]: 36. Transfusion Fresh Frozen Plasma? yes no 36.1 Number of FFP units given [0-20]: 37. Transfusion platelets? yes no 37.1 Number of platelets units given [1-5]: 38. Fluid balance available? yes no 38.1 If yes, specify volume [ ]: ml 38.2 If yes, balance positive or negative positive negative End of Critical Care stay / Lost to follow-up 39. End of CriticaI Care stay? yes no 39.1 If yes, specify: discharge to ward transfer to other hospital deceased discharge to home 40. At end of CriticaI Care stay, specify total duration of stay [0-144]: hours 41. Lost to follow-up? yes no 41.1 If yes, specify: informed consent retracted other 41.2 If other, specify reason: If discharge to ward; please continue data recording on CRF 2A Non Critical Care Follow Up LAS VEGAS_CRF2B_Critical Care F/U, Final version #2.1 dated 28 September 2012 page 7 of 14
20 LAS VEGAS Critical Care Follow up DAY 3 Post-Operative Time: from 00:00 h to 23:59h 1. Day 3 follow up performed? yes no 2. If yes, date [>14-FEB-2013]: 3. APACHE II score [0-71]: If APACHE II is already scored on a previous day, in case of new admission (score within first 24h) please fill 00 Daily score (on morning round; i.e. closest to 08:00 AM. In case of new admission at first hour of CCU admission) 1. SOFA score [0-24]: 2. Invasive mechanical ventilation? yes no 2.1 Total hours of invasive MV [0-24]: hours from 00:00h to 23:59h 3. Non-invasive mechanical ventilation? yes no 3.1 If non-invasive, specify type of interface mask helmet 3.2 Total hours of non-invasive MV [0-24]: hours from 00:00h to 23:59h 4. Tracheal extubation on day 3? n/a yes no 5. Re-intubation on day 3? n/a yes no Mechanical Ventilation from 00:00 h to 23:59h 92. Hours of controlled MV [0-24]: hours i.e. pressure control; volume control 93. Hours of assisted MV [0-24]: hours i.e. ASB 94. Hours of combined controlled/assisted MV [0-24]: hours i.e. ASV, SIMV 95. Hours of CPAP [0-24]: hours Ppeak [20-60 cmh2o] Pplat (if available) [10-50 cmh2o] TV [ ml] PEEP [0-30 cmh2o] Resp Rate [1-60 /min] Highest Lowest Highest Lowest Highest Lowest Highest Lowest Highest Lowest RM FiO2 [20-100%] ph [ ] PaCO2 [ mmhg] or [1-40 kpa] PaO2 [ mmhg] or [1-80 kpa] Yes* No Highest Lowest Highest Lowest Highest Lowest Highest Lowest *if yes, tick all that apply LAS VEGAS_CRF2B_Critical Care F/U, Final version #2.1 dated 28 September 2012 page 8 of 14
21 Pulmonary complications 6. Pneumonia? yes no presence of a new or progressive radiographic infiltrate plus at least two of three clinical features (fever >38 C or >100.4 F, leucocytosis or leucopenia and purulent secretions) 7. ARDS? yes no 7.1 If yes, specify severity of ARDS mild moderate severe according to Berlin definition of ARDS 8. Pneumothorax? yes no air in the pleural space with no vascular bed surrounding the visceral pleura on CXR Extra-pulmonary organ failure 9. Acute kidney failure? yes no 9.1 If yes, staging by RIFLE criteria risk injury failure loss end-stage definitions on page Renal replacement therapy? yes no 11. Circulatory failure? yes no defined as; need for vaso-active drugs 12. Any new arrhythmias? yes no definition on page 14 Transfusion of fluids 13. Transfusion PRBC? yes no 13.1 Number of PRBC units given [0-20]: 14. Transfusion Fresh Frozen Plasma? yes no 14.1 Number of FFP units given [0-20]: 15. Transfusion platelets? yes no 15.1 Number of platelets units given [1-5]: 16. Fluid balance available? yes no 16.1 If yes, specify volume [ ]: ml 16.2 If yes, balance positive or negative positive negative End of Critical Care stay / Lost to follow-up 17. End of CriticaI Care stay? yes no 17.1 If yes, specify: discharge to ward transfer to other hospital deceased discharge to home 18. At end of CriticaI Care stay, specify total duration of stay [0-144]: hours 19. Lost to follow-up? yes no 19.1 If yes, specify: informed consent retracted other 19.2 If other, specify reason: If discharge to ward; please continue data recording on CRF 2A Non Critical Care Follow Up LAS VEGAS_CRF2B_Critical Care F/U, Final version #2.1 dated 28 September 2012 page 9 of 14
22 LAS VEGAS Critical Care Follow up DAY 4 Post-Operative Time: from 00:00 h to 23:59h 1. Day 4 follow up performed? yes no 2. If yes, date [>14-FEB-2013]: 3. APACHE II score [0-71]: If APACHE II is already scored on a previous day, in case of new admission (score within first 24h) please fill 00 Daily score (on morning round; i.e. closest to 08:00 AM. In case of new admission at first hour of CCU admission) 1. SOFA score [0-24]: 2. Invasive mechanical ventilation? yes no 2.1 Total hours of invasive MV [0-24]: hours from 00:00h to 23:59h 3. Non-invasive mechanical ventilation? yes no 3.1 If non-invasive, specify type of interface mask helmet 3.2 Total hours of non-invasive MV [0-24]: hours from 00:00h to 23:59h 4. Tracheal extubation on day 4? n/a yes no 5. Re-intubation on day 4? n/a yes no Mechanical Ventilation from 00:00 h to 23:59h 115. Hours of controlled MV [0-24]: hours i.e. pressure control; volume control 116. Hours of assisted MV [0-24]: hours i.e. ASB 117. Hours of combined controlled/assisted MV [0-24]: hours i.e. ASV, SIMV 118. Hours of CPAP [0-24]: hours Ppeak [20-60 cmh2o] Pplat (if available) [10-50 cmh2o] TV [ ml] PEEP [0-30 cmh2o] Resp Rate [1-60 /min] Highest Lowest Highest Lowest Highest Lowest Highest Lowest Highest Lowest RM FiO2 [20-100%] ph [ ] PaCO2 [ mmhg] or [1-40 kpa] PaO2 [ mmhg] or [1-80 kpa] Yes* No Highest Lowest Highest Lowest Highest Lowest Highest Lowest *if yes, tick all that apply LAS VEGAS_CRF2B_Critical Care F/U, Final version #2.1 dated 28 September 2012 page 10 of 14
23 Pulmonary complications 6. Pneumonia? yes no presence of a new or progressive radiographic infiltrate plus at least two of three clinical features (fever >38 C or >100.4 F, leucocytosis or leucopenia and purulent secretions) 7. ARDS? yes no 7.1 If yes, specify severity of ARDS mild moderate severe according to Berlin definition of ARDS 8. Pneumothorax? yes no air in the pleural space with no vascular bed surrounding the visceral pleura on CXR Extra-pulmonary organ failure 9. Acute kidney failure? yes no 9.1 If yes, staging by RIFLE criteria risk injury failure loss end-stage definitions on page Renal replacement therapy? yes no 11. Circulatory failure? yes no defined as; need for vaso-active drugs 12. Any new arrhythmias? yes no definition on page 14 Transfusion of fluids 13. Transfusion PRBC? yes no 13.1 Number of PRBC units given [0-20]: 14. Transfusion Fresh Frozen Plasma? yes no 14.1 Number of FFP units given [0-20]: 15. Transfusion platelets? yes no 15.1 Number of platelets units given [1-5]: 16. Fluid balance available? yes no 16.1 If yes, specify volume [ ]: ml 16.2 If yes, balance positive or negative positive negative End of Critical Care stay / Lost to follow-up 17. End of CriticaI Care stay? yes no 17.1 If yes, specify: discharge to ward transfer to other hospital deceased discharge to home 18. At end of CriticaI Care stay, specify total duration of stay [0-144]: hours 19. Lost to follow-up? yes no 19.1 If yes, specify: informed consent retracted other 19.2 If other, specify reason: If discharge to ward; please continue data recording on CRF 2A Non Critical Care Follow Up LAS VEGAS_CRF2B_Critical Care F/U, Final version #2.1 dated 28 September 2012 page 11 of 14
24 LAS VEGAS Critical Care Follow up DAY 5 Post-Operative Time: from 00:00 h to 23:59h 1. Day 5 follow up performed? yes no 2. If yes, date [>14-FEB-2013]: 3. APACHE II score [0-71]: If APACHE II is already scored on a previous day, in case of new admission (score within first 24h) please fill 00 Daily score (on morning round; i.e. closest to 08:00 AM. In case of new admission at first hour of CCU admission) 1. SOFA score [0-24]: 2. Invasive mechanical ventilation? yes no 2.1 Total hours of invasive MV [0-24]: hours from 00:00h to 23:59h 3. Non-invasive mechanical ventilation? yes no 3.1 If non-invasive, specify type of interface mask helmet 3.2 Total hours of non-invasive MV [0-24]: hours from 00:00h to 23:59h 4. Tracheal extubation on day 5? n/a yes no 5. Re-intubation on day 5? n/a yes no Mechanical Ventilation from 00:00 h to 23:59h 138. Hours of controlled MV [0-24]: hours i.e. pressure control; volume control 139. Hours of assisted MV [0-24]: hours i.e. ASB 140. Hours of combined controlled/assisted MV [0-24]: hours i.e. ASV, SIMV 141. Hours of CPAP [0-24]: hours Ppeak [20-60 cmh2o] Pplat (if available) [10-50 cmh2o] TV [ ml] PEEP [0-30 cmh2o] Resp Rate [1-60 /min] Highest Lowest Highest Lowest Highest Lowest Highest Lowest Highest Lowest RM FiO2 [20-100%] ph [ ] PaCO2 [ mmhg] or [1-40 kpa] PaO2 [ mmhg] or [1-80 kpa] Yes* No Highest Lowest Highest Lowest Highest Lowest Highest Lowest *if yes, tick all that apply LAS VEGAS_CRF2B_Critical Care F/U, Final version #2.1 dated 28 September 2012 page 12 of 14
25 Pulmonary complications 6. Pneumonia? yes no presence of a new or progressive radiographic infiltrate plus at least two of three clinical features (fever >38 C or >100.4 F, leucocytosis or leucopenia and purulent secretions) 7. ARDS? yes no 7.1 If yes, specify severity of ARDS mild moderate severe according to Berlin definition of ARDS 8. Pneumothorax? yes no air in the pleural space with no vascular bed surrounding the visceral pleura on CXR Extra-pulmonary organ failure 9. Acute kidney failure? yes no 9.1 If yes, staging by RIFLE criteria risk injury failure loss end-stage definitions on page Renal replacement therapy? yes no 11. Circulatory failure? yes no defined as; need for vaso-active drugs 12. Any new arrhythmias? yes no definition on page 14 Transfusion of fluids 13. Transfusion PRBC? yes no 13.1 Number of PRBC units given [0-20]: 14. Transfusion Fresh Frozen Plasma? yes no 14.1 Number of FFP units given [0-20]: 15. Transfusion platelets? yes no 15.1 Number of platelets units given [1-5]: 16. Fluid balance available? yes no 16.1 If yes, specify volume [ ]: ml 16.2 If yes, balance positive or negative positive negative End of Critical Care stay / Lost to follow-up 17. End of CriticaI Care stay? yes no 17.1 If yes, specify: discharge to ward transfer to other hospital deceased discharge to home 18. At end of CriticaI Care stay, specify total duration of stay [0-144]: hours 19. Lost to follow-up? yes no 19.1 If yes, specify: informed consent retracted other 19.2 If other, specify reason: If discharge to ward; please continue data recording on CRF 2A Non Critical Care Follow Up LAS VEGAS_CRF2B_Critical Care F/U, Final version #2.1 dated 28 September 2012 page 13 of 14
26 Ventilatory Modes Guide intra-operative values - Volume Control: VC - Pressure Control: PC - Pressure Support Ventilation: PSV - Adaptive Support Ventilation: ASV - Synchronized Intermittend Mandatory Ventilation: SIMV - Assisted Spontaneous Breathing: ASB - Other (for example high frequency oscillatory ventilation (HFOV), jet ventilation) Recruitment Maneuvers (RM) - Incremental PEEP (PEEP): stepwise increases in PEEP at constant tidal volume, mostly in steps of 5 cmh 20, until peak/plateau positive airway pressure above 30 cmh 20 is reached. PEEP is sustained for 3 or more breaths and then returned back to baseline ventilation. - Tidal volume recruitment (TV): stepwise increases in tidal volume until peak/plateau positive airway pressure above 30 cmh 20 is reached at constant PEEP level. At least 3 breaths with the plateau pressure of above 30 cmh 20 are performed, before returning back to baseline ventilation. - Combined tidal and PEEP recruitment (TV/PEEP): PEEP and tidal volume are both stepwise increased to reach a plateau pressure above 30 cmh 20. At least 3 breaths with the plateau pressure > 30 cmh 20 are performed, before returning back to baseline ventilation. - Inspiratory holds (Insp): also called CPAP maneuvers. During this kind of maneuver a positive airway pressure above 30 cmh 20 is applied for 10 to 30 seconds and then returned back to baseline ventilation. - Sustained inflation with bag (Bag): manual hyperinflation using balloon/bag New onset arrhythmias: Defined as new onset of atrial fibrillation [AF], sustained ventricular tachycardia [VT], supraventricular tachycardia [SVT], and ventricular fibrillation [VF]. For further definitions of AF, VT, SVT and VF; see Appendix 1 of protocol The RIFLE criteria, staging of patients with acute kidney injury: - Risk: GFR decrease >25%, serum creatinine increased 1.5 times or urine production of <0.5 ml/kg/hr for 6 hours - Injury: GFR decrease >50%, doubling of creatinine or urine production <0.5 ml/kg/hr for 12 hours - Failure: GFR decrease >75%, tripling of creatinine or creatinine >355 μmol/l (with a rise of >44) (>4 mg/dl) OR urine output below 0.3 ml/kg/hr for 24 hours - Loss: persistent AKI or complete loss of kidney function for more than 4 weeks - End-stage renal disease: complete loss of kidney function for more than 3 months LAS VEGAS_CRF2B_Critical Care F/U, Final version #2.1 dated 28 September 2012 page 14 of 14
27 LAS VEGAS Case Report Form 3 - DAY Day 28 follow up performed? yes no 2. Date day 28: [>=14-MAR-2013]: Hospital discharge or death 3. Patient status at day 28: alive in hospital ward alive in critical care unit choose single most appropriate alive discharged dead 3.1 Date of Hospital discharge or In Hospital death: [>=14-FEB-2013] if discharged or dead LAS VEGAS_CRF3_Day 28, Final version #2.1 dated 28 September 2012 page 1 of 1
SECTION 1: INCLUSION, EXCLUSION & RANDOMISATION INFORMATION
SECTION 1: INCLUSION, EXCLUSION & RANDOMISATION INFORMATION DEMOGRAPHIC INFORMATION Given name Family name Date of birth Consent date Gender Female Male Date of surgery INCLUSION & EXCLUSION CRITERIA YES
More informationINternational observational study To Understand the impact and BEst practices of airway management in critically ill patients CASE REPORT FORM
INternational observational study To Understand the impact and BEst practices of airway management in critically ill patients Study acronym identifier: INTUBE CASE REPORT FORM Centre ID number: Patient
More informationPATIENT CHARACTERISTICS AND PREOPERATIVE DATA (ecrf 1).
PATIENT CHARACTERISTICS AND PREOPERATIVE DATA (ecrf 1). 1 Inform Consent Date: / / dd / Mmm / yyyy 2 Patient identifier: Please enter the 6 digit Patient identification number from your site patient log
More informationSECTION 1: INCLUSION, EXCLUSION & RANDOMISATION INFORMATION
SECTION 1: INCLUSION, EXCLUSION & RANDOMISATION INFORMATION DEMOGRAPHIC INFORMATION Given name Family name Date of birth Consent date (DD/MMM/YYYY) (DD/MMM/YYYY) Gender Female Male Date of surgery (DD/MMM/YYYY)
More informationDAILY SCREENING FORM
DAILY SCREENING FORM Patient s initials: Date of admission: Time of admission: Gender: M F Year of Birth: Type of admission: Medical/Surgical/Postoperative (elective) Days Date Mechanical ventilation Lung
More informationCanadian Trauma Trials Collaborative. Occult Pneumothorax in Critical Care (OPTICC): Standardized Data Collection Sheet
Canadian Trauma Trials Collaborative STUDY CENTRE: Institution: City / Province: / Occult Pneumothorax in Critical Care (OPTICC): Standardized Sheet PATIENT DEMOGRAPHICS: First Name: Health record number
More informationCASE REPORT FORM (v )
INternational observational study To Understand the impact and BEst practices of airway management in critically ill patients Study acronym identifier: INTUBE CASE REPORT FORM (v 1.2 30.09.18) SITE INFORMATION
More informationWorldwidE AssessmeNt of Separation of patients From ventilatory assistance WEAN SAFE
European Society of Intensive Care Medicine (ESICM) Acute Respiratory Failure Section ESICM Trial Group WorldwidE AssessmeNt of Separation of patients From ventilatory assistance WEAN SAFE Data Collection
More informationMechanical Ventilation Principles and Practices
Mechanical Ventilation Principles and Practices Dr LAU Chun Wing Arthur Department of Intensive Care Pamela Youde Nethersole Eastern Hospital 6 October 2009 In this lecture, you will learn Major concepts
More informationWeaning from Mechanical Ventilation. Dr Azmin Huda Abdul Rahim
Weaning from Mechanical Ventilation Dr Azmin Huda Abdul Rahim Content Definition Classification Weaning criteria Weaning methods Criteria for extubation Introduction Weaning comprises 40% of the duration
More informationSECTION 1: INCLUSION/EXCLUSION CRITERIA INCLUSION CRITERIA Please put a cross in the Yes or No box for each question
Site Number Patient s Initials SECTION 1: INCLUSION/EXCLUSION CRITERIA INCLUSION CRITERIA Please put a cross in the Yes or No box for each question Yes No 1.1 Is the patient receiving invasive mechanical
More informationEuropean Society of Intensive Care Medicine (ESICM) Acute Respiratory Failure Section WEAN SAFE. Data Collection Forms
European Society of Intensive Care Medicine (ESICM) Acute Respiratory Failure Section WEAN SAFE Data Collection Forms Study ID: Date of Data collection: FORM 0: - ORGANIZATIONAL DATA OF THE PARTICIPATING
More informationProne ventilation revisited in H1N1 patients
International Journal of Advanced Multidisciplinary Research ISSN: 2393-8870 www.ijarm.com DOI: 10.22192/ijamr Volume 5, Issue 10-2018 Case Report DOI: http://dx.doi.org/10.22192/ijamr.2018.05.10.005 Prone
More informationRespiratory insufficiency in bariatric patients
Respiratory insufficiency in bariatric patients Special considerations or just more of the same? Weaning and rehabilation conference 6th November 2015 Definition of obesity Underweight BMI< 18 Normal weight
More informationPostoperative Respiratory failure( PRF) Dr.Ahmad farooq
Postoperative Respiratory failure( PRF) Dr.Ahmad farooq Is it really or/only a postoperative issue Multi hit theory first hits second hits Definition Pulmonary gas exchange impairment that presents after
More informationOxygenation Failure. Increase FiO2. Titrate end-expiratory pressure. Adjust duty cycle to increase MAP. Patient Positioning. Inhaled Vasodilators
Oxygenation Failure Increase FiO2 Titrate end-expiratory pressure Adjust duty cycle to increase MAP Patient Positioning Inhaled Vasodilators Extracorporeal Circulation ARDS Radiology Increasing Intensity
More informationSurgery Grand Rounds. Non-invasive Ventilation: A valuable tool. James Cromie, PGY 3 8/24/09
Surgery Grand Rounds Non-invasive Ventilation: A valuable tool James Cromie, PGY 3 8/24/09 History of mechanical ventilation 1930 s: use of iron lung 1940 s: First NIV system (Bellevue Hospital) 1950 s:
More informationARDS Management Protocol
ARDS Management Protocol February 2018 ARDS Criteria Onset Within 1 week of a known clinical insult or new or worsening respiratory symptoms Bilateral opacities not fully explained by effusions, lobar/lung
More informationNIV in Acute Respiratory Failure: Where we fail? Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity
NIV in Acute Respiratory Failure: Where we fail? Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity Use of NIV 1998-2010 50 45 40 35 30 25 20 15 10 5 0 1998
More informationComposite of pneumonia, re-intubation, or death within 30 days of randomisation.
Appendix: definitions Clinical outcome measures Primary outcome measure Composite of pneumonia, re-intubation, or death within 30 days of randomisation. Pneumonia Care will be taken to distinguish between
More informationNON-INVASIVE VENTILATION. Lijun Ding 23 Jan 2018
NON-INVASIVE VENTILATION Lijun Ding 23 Jan 2018 Learning objectives What is NIV The difference between CPAP and BiPAP The indication of the use of NIV Complication of NIV application Patient monitoring
More informationData Collection Tool. Standard Study Questions: Admission Date: Admission Time: Age: Gender:
Data Collection Tool Standard Study Questions: Admission Date: Admission Time: Age: Gender: Specifics of Injury: Time of Injury: Mechanism of Injury Blunt vs Penetrating? Injury Severity Score? Injuries:
More informationPrepared by : Bayan Kaddourah RN,MHM. GICU Clinical Instructor
Mechanical Ventilation Prepared by : Bayan Kaddourah RN,MHM. GICU Clinical Instructor 1 Definition Is a supportive therapy to facilitate gas exchange. Most ventilatory support requires an artificial airway.
More informationHandling Common Problems & Pitfalls During. Oxygen desaturation in patients receiving mechanical ventilation ACUTE SEVERE RESPIRATORY FAILURE
Handling Common Problems & Pitfalls During ACUTE SEVERE RESPIRATORY FAILURE Pravit Jetanachai, MD QSNICH Oxygen desaturation in patients receiving mechanical ventilation Causes of oxygen desaturation 1.
More informationAPRV Ventilation Mode
APRV Ventilation Mode Airway Pressure Release Ventilation A Type of CPAP Continuous Positive Airway Pressure (CPAP) with an intermittent release phase. Patient cycles between two levels of CPAP higher
More informationTrial protocol - NIVAS Study
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 Trial protocol - NIVAS Study METHODS Study oversight The Non-Invasive Ventilation after Abdominal Surgery
More informationMechanical Ventilation 1. Shari McKeown, RRT Respiratory Services - VGH
Mechanical Ventilation 1 Shari McKeown, RRT Respiratory Services - VGH Objectives Describe indications for mcvent Describe types of breaths and modes of ventilation Describe compliance and resistance and
More informationExclusion Criteria 1. Operator or supervisor feels specific intra- procedural laryngoscopy device will be required.
FELLOW Study Data Analysis Plan Direct Laryngoscopy vs Video Laryngoscopy Background Respiratory failure requiring endotracheal intubation occurs in as many as 40% of critically ill patients. Procedural
More informationYou are caring for a patient who is intubated and. pressure control ventilation. The ventilator. up to see these scalars
Test yourself Test yourself #1 You are caring for a patient who is intubated and ventilated on pressure control ventilation. The ventilator alarms and you look up to see these scalars What is the most
More informationAirway management problem during anaesthesia. Airway management problem in ICU / HDU. Airway management problem occurring in the Emergency Department
4th National Audit Project of the Royal College of Anaesthetists: Major Complications of Airway Management in the UK Please select one form from the list below Airway management problem during anaesthesia
More informationCSIM annual meeting Acute respiratory failure. Dr. John Ronald, FRCPC Int Med, Resp, CCM. October 10, 2018
CSIM annual meeting - 2018 Acute respiratory failure Dr. John Ronald, FRCPC Int Med, Resp, CCM. October 10, 2018 NRGH affiliated with UBC medicine Disclosures None relevant to this presentation. Also no
More informationWeaning and extubation in PICU An evidence-based approach
Weaning and extubation in PICU An evidence-based approach Suchada Sritippayawan, MD. Div. Pulmonology & Crit Care Dept. Pediatrics Faculty of Medicine Chulalongkorn University Kanokporn Udomittipong, MD.
More informationCLINICAL VIGNETTE 2016; 2:3
CLINICAL VIGNETTE 2016; 2:3 Editor-in-Chief: Olufemi E. Idowu. Neurological surgery Division, Department of Surgery, LASUCOM/LASUTH, Ikeja, Lagos, Nigeria. Copyright- Frontiers of Ikeja Surgery, 2016;
More informationCase Scenarios. Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC. Consultant, Critical Care Medicine Medanta, The Medicity
Case Scenarios Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity Case 1 A 36 year male with cirrhosis and active GI bleeding is intubated to protect his airway,
More informationFacilitating EndotracheaL Intubation by Laryngoscopy technique and Apneic Oxygenation Within the Intensive Care Unit (FELLOW)
Facilitating EndotracheaL Intubation by Laryngoscopy technique and Apneic Oxygenation Within the Intensive Data Analysis Plan: Apneic Oxygenation vs. No Apneic Oxygenation Background Critically ill patients
More informationARDS: an update 6 th March A. Hakeem Al Hashim, MD, FRCP SQUH
ARDS: an update 6 th March 2017 A. Hakeem Al Hashim, MD, FRCP SQUH 30M, previously healthy Hx: 1 week dry cough Gradually worsening SOB No travel Hx Case BP 130/70, HR 100/min ph 7.29 pco2 35 po2 50 HCO3
More informationWhat is the next best step?
Noninvasive Ventilation William Janssen, M.D. Assistant Professor of Medicine National Jewish Health University of Colorado Denver Health Sciences Center What is the next best step? 65 year old female
More informationOutcomes From Severe ARDS Managed Without ECMO. Roy Brower, MD Johns Hopkins University Critical Care Canada Forum Toronto November 1, 2016
Outcomes From Severe ARDS Managed Without ECMO Roy Brower, MD Johns Hopkins University Critical Care Canada Forum Toronto November 1, 2016 Severe ARDS Berlin Definition 2012 P:F ratio 100 mm Hg Prevalence:
More informationProtocol ID: LAS VEGAS Study Protocol Version 1.2 Amendment 1, dated 20-November-2012 Clinicaltrials.gov identifier: NCT
Local Assessment of Ventilatory Management During General Anesthesia for Surgery and effects on Postoperative Pulmonary Complications: a Prospective Observational International Multi center Cohort Study
More informationProvide guidelines for the management of mechanical ventilation in infants <34 weeks gestation.
Page 1 of 5 PURPOSE: Provide guidelines for the management of mechanical ventilation in infants
More informationARDS Assisted ventilation and prone position. ICU Fellowship Training Radboudumc
ARDS Assisted ventilation and prone position ICU Fellowship Training Radboudumc Fig. 1 Physiological mechanisms controlling respiratory drive and clinical consequences of inappropriate respiratory drive
More informationEffects of PPV on the Pulmonary System. Chapter 17
Effects of PPV on the Pulmonary System Chapter 17 Pulmonary Complications Lung Injury Gas distribution Pulmonary blood flow VAP Hypoventilation Hyperventilation Air trapping Oxygen toxicity WOB Patient-Ventilator
More informationIndex. Note: Page numbers of article titles are in boldface type
Index Note: Page numbers of article titles are in boldface type A Acute coronary syndrome, perioperative oxygen in, 599 600 Acute lung injury (ALI). See Lung injury and Acute respiratory distress syndrome.
More informationAPPENDIX VI HFOV Quick Guide
APPENDIX VI HFOV Quick Guide Overall goal: Maintain PH in the target range at the minimum tidal volume. This is achieved by favoring higher frequencies over lower P (amplitude). This goal is also promoted
More informationNIV use in ED. Dr. Khalfan AL Amrani Emergency Resuscitation Symposium 2 nd May 2016 SQUH
NIV use in ED Dr. Khalfan AL Amrani Emergency Resuscitation Symposium 2 nd May 2016 SQUH Outline History & Introduction Overview of NIV application Review of proven uses of NIV History of Ventilation 1940
More informationBy Mark Bachand, RRT-NPS, RPFT. I have no actual or potential conflict of interest in relation to this presentation.
By Mark Bachand, RRT-NPS, RPFT I have no actual or potential conflict of interest in relation to this presentation. Objectives Review state protocols regarding CPAP use. Touch on the different modes that
More informationLearning Objectives. 1. Indications versus contra-indications 2. CPAP versus NiVS 3. Clinical evidence
Learning Objectives 1. Indications versus contra-indications 2. CPAP versus NiVS 3. Clinical evidence Pre-hospital Non-invasive vventilatory support Marc Gillis, MD Imelda Bonheiden Our goal out there
More informationRecent Advances in Respiratory Medicine
Recent Advances in Respiratory Medicine Dr. R KUMAR Pulmonologist Non Invasive Ventilation (NIV) NIV Noninvasive ventilation (NIV) refers to the administration of ventilatory support without using an invasive
More informationOptimize vent weaning and SBT outcomes. Identify underlying causes for SBT failures. Role SBT and weaning protocol have in respiratory care
Optimize vent weaning and SBT outcomes Identify underlying causes for SBT failures Role SBT and weaning protocol have in respiratory care Lower risk of developing complications Lower risk of VAP, other
More informationConcerns and Controversial Issues in NPPV. Concerns and Controversial Issues in Noninvasive Positive Pressure Ventilation
: Common Therapy in Daily Practice Concerns and Controversial Issues in Noninvasive Positive Pressure Ventilation Rongchang Chen Guangzhou Institute of Respiratory Disease as the first choice of mechanical
More informationNAVA. In Neonates. Howard Stein, M.D. Director Neonatology. Neurally Adjusted Ventilatory Assist. Toledo Children s Hospital Toledo, Ohio
NAVA Neurally Adjusted Ventilatory Assist In Neonates Howard Stein, M.D. Director Neonatology Toledo Children s Hospital Toledo, Ohio Disclaimers Dr Stein: Is discussing products made by Maquet Has no
More informationDr. Yasser Fathi M.B.B.S, M.Sc, M.D. Anesthesia Consultant, Head of ICU King Saud Hospital, Unaizah
BY Dr. Yasser Fathi M.B.B.S, M.Sc, M.D Anesthesia Consultant, Head of ICU King Saud Hospital, Unaizah Objectives For Discussion Respiratory Physiology Pulmonary Graphics BIPAP Graphics Trouble Shootings
More informationProposed presentation of data for ICU-ROX.
Proposed presentation of data for ICU-ROX. Version 1 was posted online on 21 November 2017 (prior to the interim analysis which occurred when the 500 th participant reached day 28). This version (version
More information7 Initial Ventilator Settings, ~05
Abbreviations (inside front cover and back cover) PART 1 Basic Concepts and Core Knowledge in Mechanical -- -- -- -- 1 Oxygenation and Acid-Base Evaluation, 1 Review 01Arterial Blood Gases, 2 Evaluating
More informationOSCAR & OSCILLATE. & the Future of High Frequency Oscillatory Ventilation (HFOV)
& & the Future of High Frequency Oscillatory Ventilation (HFOV) www.philippelefevre.com What do we know already? Sud S et al. BMJ 2010 & Multi-centre randomised controlled trials of HFOV verses current
More informationAFCH NEUROMUSCULAR DISORDERS (NMD) PROTOCOL
AFCH NEUROMUSCULAR DISORDERS (NMD) PROTOCOL A. Definition of Therapy: 1. Cough machine: 4 sets of 5 breaths with a goal of I:E pressures approximately the same of 30-40. Inhale time = 1 second, exhale
More informationProblem Based Learning. Problem. Based Learning
Problem 2013 Based Learning Problem Based Learning Your teacher presents you with a problem in anesthesia, our learning becomes active in the sense that you discover and work with content that you determine
More informationAddendum/database Part 1 demographics
Addendum/database Part 1 demographics Part 1 General demographics Section finished? Date Time of alarm 08.00-17.00h 17.00-23.00h 23.00-08.00h Transport unit MICU / ITW IC ambulance Standard ambulance Helicopter
More informationApplication of Lung Protective Ventilation MUST Begin Immediately After Intubation
Conflict of Interest Disclosure Robert M Kacmarek Managing Severe Hypoxemia!" 9-28-17 FOCUS Bob Kacmarek PhD, RRT Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts I disclose
More informationINTELLiVENT -ASV insight. Alexandra Geiger CAS, Dr. Marc Wysocki, Head of Medical Research Hamilton Medical
INTELLiVENT -ASV insight Alexandra Geiger CAS, Dr. Marc Wysocki, Head of Medical Research Hamilton Medical First Automation of HAMILTON MEDICAL 1998 Adaptive Support Ventilation (ASV) ASV optimize VT and
More informationUniversity of Bristol - Explore Bristol Research
Rogers, C., Capoun, R., Scott, L., Taylor, J., Angelini, G., Narayan, P.,... Ascione, R. (2017). Shortening cardioplegic arrest time in patients undergoing combined coronary and valve surgery: results
More informationEAST MULTICENTER STUDY DATA COLLECTION TOOL
EAST MULTICENTER STUDY DATA COLLECTION TOOL Multicenter Study: Effect of Regional Anesthesia on Delirium in Geriatric Trauma Patients with Multiple Rib Fractures Enrolling Center: Enrolling Co-investigators:
More informationA 74-year-old man with severe ischemic cardiomyopathy and atrial fibrillation
1 A 74-year-old man with severe ischemic cardiomyopathy and atrial fibrillation The following 3 minute polysomnogram (PSG) tracing was recorded in a 74-year-old man with severe ischemic cardiomyopathy
More informationSupplementary Online Content 2
Supplementary Online Content 2 van Meenen DMP, van der Hoeven SM, Binnekade JM, et al. Effect of on demand vs routine nebulization of acetylcysteine with salbutamol on ventilator-free days in intensive
More informationICU management and referral guidelines for severe hypoxic respiratory failure
Aim: ICU management and referral guidelines for severe hypoxic respiratory failure 1) To provide a concise management plan Non ventilatory Ventilatory 2) Timeline for referring patient with refractory
More informationNoninvasive respiratory support:why is it working?
Noninvasive respiratory support:why is it working? Paolo Pelosi Department of Surgical Sciences and Integrated Diagnostics (DISC) IRCCS San Martino IST University of Genoa, Genoa, Italy ppelosi@hotmail.com
More informationBronchoalveolar lavage (BAL) with surfactant in pediatric ARDS
Bronchoalveolar lavage (BAL) with surfactant in pediatric ARDS M. Luchetti, E. M. Galassini, A. Galbiati, C. Pagani,, F. Silla and G. A. Marraro gmarraro@picu.it www.picu.it Anesthesia and Intensive Care
More informationPOLICY. Number: Title: APPLICATION OF NON INVASIVE VENTILATION FOR ACUTE RESPIRATORY FAILURE. Authorization
POLICY Number: 7311-60-024 Title: APPLICATION OF NON INVASIVE VENTILATION FOR ACUTE RESPIRATORY FAILURE Authorization [ ] President and CEO [ x ] Vice President, Finance and Corporate Services Source:
More informationLandmark articles on ventilation
Landmark articles on ventilation Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity ARDS AECC DEFINITION-1994 ALI Acute onset Bilateral chest infiltrates PCWP
More informationYear in Review Intensive Care Training Program Radboud University Medical Centre Nijmegen
Year in Review 2013 Intensive Care Training Program Radboud University Medical Centre Nijmegen Contents ARDS Ventilator associated pneumonia Tracheostomy and endotracheal intubation Enteral feeding Fluid
More informationNIV - BI-LEVEL POSITIVE AIRWAY PRESSURE (BIPAP)
Introduction NIV - BI-LEVEL POSITIVE AIRWAY PRESSURE (BIPAP) Noninvasive ventilation (NIV) is a method of delivering oxygen by positive pressure mask that allows for the prevention or postponement of invasive
More informationCardiorespiratory Physiotherapy Tutoring Services 2017
VENTILATOR HYPERINFLATION ***This document is intended to be used as an information resource only it is not intended to be used as a policy document/practice guideline. Before incorporating the use of
More informationDiagnosis and Management of Acute Respiratory Failure
Diagnosis and Management of Acute Respiratory Failure Steven B. Leven, M.D., F.C.C.P. Clinical Professor, Pulmonary/Critical Care Medicine UCI Director MICU and Respiratory Therapy, UCI Medical Center
More informationMECHANICAL VENTILATION PROTOCOLS
GENERAL or SURGICAL Initial Ventilator Parameters Ventilator Management (see appendix I) Assess Patient Data (see appendix II) Data Collection Mode: Tidal Volume: FIO2: PEEP: Rate: I:E Ratio: ACUTE PHASE
More informationVentilatory Management of ARDS. Alexei Ortiz Milan; MD, MSc
Ventilatory Management of ARDS Alexei Ortiz Milan; MD, MSc 2017 Outline Ventilatory management of ARDS Protected Ventilatory Strategy Use of NMB Selection of PEEP Driving pressure Lung Recruitment Prone
More informationSepsis: Management ANUPOL PANITCHOTE, MD. Division of Critical Care Medicine Department of Medicine, Khon Kaen University, Thailand
Sepsis: Management ANUPOL PANITCHOTE, MD. Division of Critical Care Medicine Department of Medicine, Khon Kaen University, Thailand Vital signs Symptoms LAB BT > 38.3 or < 36 ๐ C HR > 90 bpm RR > 20 /min
More informationBiPAPS/TVAPSCPAPASV???? Lori Davis, B.Sc., R.C.P.T.(P), RPSGT
BiPAPS/TVAPSCPAPASV???? Lori Davis, B.Sc., R.C.P.T.(P), RPSGT Modes Continuous Positive Airway Pressure (CPAP): One set pressure which is the same on inspiration and expiration Auto-PAP (APAP) - Provides
More informationNon-Invasive Ventilation
Khusrav Bajan Head Emergency Medicine, Consultant Intensivist & Physician, P.D. Hinduja National Hospital & M.R.C. 112 And the Lord God formed man of the dust of the ground and breathed into his nostrils
More informationCPAP Reduces Hypoxemia After Cardiac Surgery (CRHACS Trial). A randomized controlled trial
CPAP Reduces Hypoxemia After Cardiac Surgery (CRHACS Trial). A randomized controlled trial Backgrounds Postoperative pulmonary complications are most frequent after cardiac surgery and lead to increased
More informationGeneral OR Rotations GOALS & OBJECTIVES
General OR Rotations GOALS & OBJECTIVES Goals At the end of the CA 1 year General OR rotations, the resident should competently manage uncomplicated ambulatory, orthopedic, maxillo-facial, ENT, gynecologic,
More informationQuickLung Breather Patient Settings
The QuickLung Breather is capable of simulating a spontaneously breathing patient in a variety of modes and patterns. In response to customer requests, we have compiled five common respiratory cases below.
More informationNon-invasive Positive Pressure Mechanical Ventilation: NIPPV: CPAP BPAP IPAP EPAP. My Real Goals. What s new in 2018? OMG PAP?
Non-invasive Positive Pressure Mechanical Ventilation: What s new in 2018? Geoffrey R. Connors, MD, FACP Associate Professor of Medicine University of Colorado School of Medicine Division of Pulmonary
More informationIcu-cpr PICTURE QUIZ march 2014
Department of surgery Icu-cpr PICTURE QUIZ march 2014 Prepared by Dr. Karam Kamal Younis Assistant professor and consultant surgeon Convener of the Department of Surgery College of Medicine University
More informationAnalgesia for chest trauma - RVI
Analgesia for chest trauma - RVI Northern Network Initial Management Patients with blunt chest trauma will be managed in a standard fashion within the context of the well established trauma systems at
More informationNational Vascular Registry
National Vascular Registry AAA Repair Patient Details Patient Consent* 0 No 2 Not Required If patient not consented: Date consent recorded / / (DD/MM/YYYY) Do not record NHS number, NHS number* name(s)
More informationACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) Rv
ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) Rv.8.18.18 ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) SUDDEN PROGRESSIVE FORM OF ACUTE RESPIRATORY FAILURE ALVEOLAR CAPILLARY MEMBRANE BECOMES DAMAGED AND MORE
More informationDoes proning patients with refractory hypoxaemia improve mortality?
Does proning patients with refractory hypoxaemia improve mortality? Clinical problem and domain I selected this case because although this was the second patient we had proned in our unit within a week,
More informationACUTE RESPIRATORY DISTRESS SYNDROME
ACUTE RESPIRATORY DISTRESS SYNDROME Angel Coz MD, FCCP, DCE Assistant Professor of Medicine UCSF Fresno November 4, 2017 No disclosures OBJECTIVES Identify current trends and risk factors of ARDS Describe
More informationOnline Supplement for:
Online Supplement for: INFLUENCE OF COMBINED INTRAVENOUS AND TOPICAL ANTIBIOTIC PROPHYLAXIS ON THE INCIDENCE OF INFECTIONS, ORGAN DYSFUNCTIONS, AND MORTALITY IN CRITICALLY ILL SURGICAL PATIENTS A PROSPECTIVE,
More informationSTATE OF OKLAHOMA 2014 EMERGENCY MEDICAL SERVICES PROTOCOLS
3K NON-INVASIVE POSITIVE PRESSURE VENTILATION (NIPPV) ADULT EMT EMT-INTERMEDIATE 85 ADVANCED EMT PARAMEDIC Indications: 1. Dyspnea Uncertain Etiology Adult. 2. Dyspnea Asthma Adult. 3. Dyspnea Chronic
More informationThe use of proning in the management of Acute Respiratory Distress Syndrome
Case 3 The use of proning in the management of Acute Respiratory Distress Syndrome Clinical Problem This expanded case summary has been chosen to explore the rationale and evidence behind the use of proning
More informationI. Subject: Pressure Support Ventilation (PSV) with BiPAP Device/Nasal CPAP
I. Subject: Pressure Support Ventilation (PSV) with BiPAP Device/Nasal CPAP II. Policy: PSV with BiPAP device/nasal CPAP will be initiated upon a physician's order by Respiratory Therapy personnel trained
More informationTest Bank Pilbeam's Mechanical Ventilation Physiological and Clinical Applications 6th Edition Cairo
Instant dowload and all chapters Test Bank Pilbeam's Mechanical Ventilation Physiological and Clinical Applications 6th Edition Cairo https://testbanklab.com/download/test-bank-pilbeams-mechanical-ventilation-physiologicalclinical-applications-6th-edition-cairo/
More informationThe Art and Science of Weaning from Mechanical Ventilation
The Art and Science of Weaning from Mechanical Ventilation Shekhar T. Venkataraman M.D. Professor Departments of Critical Care Medicine and Pediatrics University of Pittsburgh School of Medicine Some definitions
More informationSepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP
Sepsis overview Dr. Tsang Hin Hung MBBS FHKCP FRCP Epidemiology Sepsis, severe sepsis, septic shock Pathophysiology of sepsis Recent researches and advances From bench to bedside Sepsis bundle Severe sepsis
More informationMechanical Ventilation ศ.พ.ญ.ส ณ ร ตน คงเสร พงศ ภาคว ชาว ส ญญ ว ทยา คณะแพทยศาสตร ศ ร ราชพยาบาล
Mechanical Ventilation ศ.พ.ญ.ส ณ ร ตน คงเสร พงศ ภาคว ชาว ส ญญ ว ทยา คณะแพทยศาสตร ศ ร ราชพยาบาล Goal of Mechanical Ventilation Mechanical ventilation is any means in which physical device or machines are
More informationBasics of NIV. Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC. Consultant, Critical Care Medicine Medanta, The Medicity
Basics of NIV Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity Objectives: Definitions Advantages and Disadvantages Interfaces Indications Contraindications
More informationMechanical Ventilation Strategies in Anesthesia
Mechanical Ventilation Strategies in Anesthesia PAOLO PELOSI, MD, FERS Department of Surgical Sciences and Integrated Diagnostics (DISC), San Martino Policlinico Hospital IRCCS for Oncology, University
More informationA Comparative Study for the Lung Mechanics during One-Lung Ventilation in Thoracic Surgeries Using Two Different Modes of Mechanical Ventilation
Med. J. Cairo Univ., Vol. 85, No. 3, June: 967-972, 2017 www.medicaljournalofcairouniversity.net A Comparative Study for the Lung Mechanics during One-Lung Ventilation in Thoracic Surgeries Using Two Different
More information